T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Benign liver tumors, such as focal nodular hyperplasia (FNH) and hepatocellular adenomas (HCA), are generally non-cancerous and often do not require aggressive treatment. However, they can still ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

hepatocellular adenoma, and hepatic cysts. The affected population usually consists of young women. Clinical management should take into account the symptoms, history, hormonal status (present and ...

Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...

Hepatic Adenoma or Focal Nodular Hyperplasia Both hepatic adenoma (see Figs. 1A,1B) and focal nodular hyperplasia (see Fig. 2) are common benign hepatic tumors. Although lesions have been reported ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...